How to Take Ozempic for Weight Loss: A Comprehensive Guide

Last reviewed: July 9, 2026

Last updated: July 9, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide injection has emerged as a powerful tool for weight management, with clinical data showing average weight loss of 15-22% over 68 weeks in adults with obesity. Understanding how this medication works, what to expect during treatment, and how to use it safely can help you make an informed decision about whether it's right for your weight loss journey. PlexusDx offers compounded semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan, with access across all 50 states and no insurance requirements.

How Semaglutide Injections Work for Weight Loss

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics a natural hormone your body produces after eating. When you inject semaglutide once weekly, it signals your brain's appetite control centers to reduce hunger, increase feelings of fullness, and slow how quickly food moves through your stomach. This combination of effects typically results in eating less food overall without feeling deprived, making sustained weight loss more achievable than with diet and exercise alone.

The medication also improves how your body handles blood sugar, which can benefit people with prediabetes or type 2 diabetes alongside weight loss goals. Research published in the New England Journal of Medicine showed that participants using semaglutide lost an average of 22.5 pounds over one year compared to 2.6 pounds in the placebo group. PlexusDx compounds semaglutide in licensed 503A pharmacies to exact specifications, ensuring consistency and quality with every injection.

Semaglutide Dosing Schedule and Your Treatment Plan

Most semaglutide treatment plans begin with a low starting dose to allow your body to adjust, then gradually increase over several weeks until reaching your maintenance dose. A typical protocol might start at 0.25 mg once weekly for four weeks, then increase by 0.25 mg each month until reaching 1.0-2.4 mg weekly, depending on your response and tolerance. The gradual increase minimizes nausea and gastrointestinal side effects while your system adapts to the medication.

PlexusDx personalizes your dosing based on your health history, metabolic profile, and genetic factors identified through the Precision Peptide Genetic Test. Your dose may need to go up as your body adapts, but your price won't—PlexusDx charges a flat monthly rate regardless of dose level, at $189/mo month-to-month, or from $149/mo on the 6-month plan for compounded semaglutide injection. Your provider will monitor your progress and adjust your dose as needed during regular check-ins to ensure you're getting optimal results.

What to Expect: Timeline, Results, and Side Effects

Most people begin noticing reduced appetite and early weight loss within the first two to three weeks of starting semaglutide, with more noticeable changes appearing by weeks four through eight. Weight loss typically accelerates during months two through six as your body becomes fully adjusted to the medication and you've developed new eating patterns. Clinical trials show that average weight loss reaches 10-15% of body weight by three months and continues through six to twelve months of consistent use.

Common side effects during the initial weeks include mild nausea, occasional vomiting, constipation, and reduced appetite for foods you normally enjoy. These effects usually diminish significantly by week three or four as your body adapts. Less common but more serious side effects can include severe nausea, pancreatitis symptoms (severe abdominal pain), or allergic reactions—notify your PlexusDx provider immediately if you experience concerning symptoms so they can adjust your treatment plan or recommend alternative therapies.

PlexusDx Semaglutide: Pricing, Access, and Genetic Personalization

PlexusDx provides compounded semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan through licensed 503A compounding pharmacies, with service available in all 50 states. Unlike traditional insurance-dependent options, PlexusDx requires no insurance verification, has no membership fees, and accepts HSA and FSA funds for additional savings. You'll work with a licensed provider who reviews your medical history, conducts initial assessments, and creates a personalized treatment plan before your first shipment arrives.

For deeper insight into your metabolic response, PlexusDx offers the Precision Peptide Genetic Test ($298), which analyzes 14 metabolic pathways and 49 peptides to identify how your genetics influence GLP-1 receptor function, appetite regulation, and weight loss potential. Key variants tested include GLP1R rs6923761 (GLP-1 receptor sensitivity), FTO rs9939609 (fat mass regulation), and MC4R rs17782313 (appetite signaling), allowing your provider to fine-tune your protocol for maximum results. This personalized approach means you're not just taking a standard dose—you're receiving therapy optimized for your unique genetic profile.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

How quickly will I lose weight on semaglutide injection?

Most patients notice reduced appetite within 1-2 weeks and measurable weight loss by 3-4 weeks. Clinical trials show average weight loss of 10-15% of body weight by three months, with continued loss through six to twelve months. Individual results vary based on diet, exercise, and your personal metabolic response, which PlexusDx can personalize using genetic testing.

Is compounded semaglutide from PlexusDx as effective as brand-name Ozempic?

PlexusDx sources compounded semaglutide from licensed 503A compounding pharmacies that follow strict pharmaceutical standards and quality controls. The active ingredient and mechanism are identical to brand medications; the main difference is cost—PlexusDx is $189/mo month-to-monthnth compared to brand-name costs of $900-$1,500+ monthly. Your provider will monitor your progress and adjust your dose based on your individual response.

Can I use my FSA or HSA to pay for PlexusDx semaglutide?

Yes, PlexusDx semaglutide injections are HSA and FSA eligible, allowing you to use pre-tax health savings to reduce your out-of-pocket cost. With no insurance required and pricing at $189/mo month-to-month, or from $149/mo on the 6-month plan, PlexusDx makes semaglutide therapy accessible across all 50 states. Contact your provider to discuss setting up HSA/FSA payments.

What side effects should I watch for, and when do they go away?

Common early side effects include nausea, constipation, and reduced appetite—most people experience these minimally by week three to four. Severe nausea, vomiting, severe abdominal pain, or signs of pancreatitis require immediate attention and should be reported to your PlexusDx provider. Your provider may adjust your dose or recommend anti-nausea strategies to improve tolerability.

How does the Precision Peptide Genetic Test help optimize my semaglutide therapy?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (FTO (rs9939609)) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Ozempic For Weight Loss 2
• Average Weight Loss On Ozempic
• Weight Loss Drugs Like Ozempic
• Ozempic Weight Loss Before And After Pictures

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.